Bio-Techne Corporation (BVMF:T1CH34)

Market Cap	41.78B -24.0%
Revenue (ttm)	6.70B +1.6%
Net Income	446.48M -48.7%
EPS	2.86 -47.0%
Shares Out	n/a
PE Ratio	93.57
Forward PE	24.60
Dividend	0.04 (0.41%)
Ex-Dividend Date	Feb 12, 2026

Volume	9
Average Volume	161
Open	9.58
Previous Close	9.48
Day's Range	8.94 - 9.58
52-Week Range	8.39 - 12.57
Beta	1.48
RSI	44.62
Earnings Date	May 1, 2026

About Bio-Techne

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue cultur...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1976
• Employees: 3,100
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: T1CH34

Financial Performance

In fiscal year 2025, Bio-Techne's revenue was $1.22 billion, an increase of 5.23% compared to the previous year's $1.16 billion. Earnings were $73.36 million, a decrease of -56.35%.

Financial numbers in USD